Outcome Following Infliximab Therapy in Children With Ulcerative Colitis

2010129 citationsJournal Article

Authors

Jeffrey S. Hyams · Connecticut Children's Medical Center

Trudy Lerer · Connecticut Children's Medical Center

Anne M. Griffiths · Hospital for Sick Children

Marian Pfefferkorn · Riley Hospital for Children

Michael C. Stephens · Medical College of Wisconsin

Jonathan Evans · Nemours Children's Clinic

Anthony Otley

Abstract

In this cohort of children with UC receiving infliximab, corticosteroid-free inactive disease was observed in 38 and 21% of patients at 12 and 24 months, respectively. By 24 months, 61% of patients had avoided colectomy.

Topics & Keywords

Inflammatory Bowel Disease Microscopic Colitis Liver Diseases and Immunity

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 105, Issue 6, pp. 1430-1436

DOI: 10.1038/ajg.2009.759

Field-Weighted Citation Impact: 8.15